2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow becatecarin: new trials by email Literature Review of becatecarin trials Research Report on becatecarin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia becatecarin, laboratory biomarker analysis - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2004-05-01 | 2013-01-23 |
| Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors becatecarin, oxaliplatin, pharmacological study - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Terminated | National Cancer Institute (NCI) | 15 | 2004-05-01 | 2013-01-10 |
| Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer filgrastim, becatecarin, cisplatin - Lymphoma, Small Intestine Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 1999-10-01 | 2013-02-11 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1)
National Cancer Institute (NCI) (3)
United States (3)
Afshin Dowlati (1) · Francis Giles (1) · Lisa Hammond, MD (1)
U01CA062461 (1), U01CA062502 (1)